M62.9

M62.9 captures a documented muscle disorder where the specific type, cause, or anatomical site cannot be further defined at the time of coding.

Verified May 8, 2026 · 6 sources ↓

Status: Billable
Chapter: 13
Related CPT: 8
Region: General

Drawn from CDCICD10DataAAPCMdclarityCMS

Documentation tips

What should appear in the chart to support M62.9.

Source · Editorial brief grounded in 6 cited references ↓

State explicitly why a more specific diagnosis could not be established — e.g., 'etiology undetermined pending EMG results' or 'presentation does not meet criteria for a named myopathy at this time.'
Record the anatomical region(s) affected, onset, duration, and functional impact even if a specific etiology is unknown; this supports medical necessity under MS-DRG 557/558 scrutiny.
Document all specific codes considered and excluded (e.g., ruled out rhabdomyolysis M62.82, ruled out sarcopenia M62.84) so the unspecified designation is defensible on audit.
If EMG, muscle biopsy, or lab results are pending at the time of coding, note the encounter stage and plan to update the code once results are available.
Avoid defaulting to M62.9 for symptoms alone — muscle pain maps to myalgia (M79.3x) and generalized weakness to M62.81; reserve M62.9 for a confirmed but incompletely characterized disorder.

Related CPT procedures

Procedure codes commonly billed with M62.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

20552 $51.77

Injection(s) into one or two muscles for single or multiple trigger points at a single session.

20553 $59.79

Injection(s) into trigger points spanning three or more muscles during a single session

95860 $119.58

Needle electromyography of one arm or leg, with or without testing of the related paraspinal muscles, to evaluate nerve and muscle function.

95861 $161.99

Needle electromyography of two extremities, including the related paraspinal muscles when they are sampled, performed without a same-day nerve conduction study.

95863 $220.45

Needle electromyography of three extremities, with related paraspinal muscles included when sampled, performed on a day with no nerve conduction testing.

95864 $240.49

Needle electromyography of all four extremities, including related paraspinal muscles if sampled, when no nerve conduction study is performed the same day.

97110 $29.06

Therapeutic exercise billed per 15-minute unit, targeting strength, endurance, range of motion, or flexibility with direct one-on-one patient contact.

97112 $32.73

Therapeutic exercise aimed at restoring balance, coordination, proprioception, posture, and movement control, billed in 15-minute units of direct contact.

Common coding pitfalls

The recurring mistakes coders make with M62.9 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Using M62.9 as a catch-all for muscle pain or weakness — M79.3x (myalgia) and M62.81 (generalized muscle weakness) are the correct codes for those symptom-level presentations.
Bypassing M62.89 (other specified disorders of muscle) when a named condition exists but lacks its own dedicated code — M62.9 is for truly unspecifiable disorders, not for conditions with a known label.
Failing to code the underlying disease first when the muscle disorder is secondary — M63.8x requires a primary-condition code, and assigning M62.9 instead obscures causal coding.
Leaving M62.9 in place after diagnostic workup confirms a specific disorder — update the code once EMG, biopsy, or lab results establish a definitive diagnosis.
Assuming M62.9 will satisfy medical necessity review without accompanying documentation explaining why specificity could not be achieved; payers under MS-DRG 557/558 will flag unsupported unspecified codes.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

M62.9 is a last-resort code for a confirmed muscle disorder when documentation does not support a more specific code within the M62 hierarchy. Before assigning M62.9, exhaust the specificity ladder: M62.81 (muscle weakness, generalized), M62.82 (rhabdomyolysis), M62.83x (muscle spasm by site), M62.84 (sarcopenia), M62.85 (multifidus dysfunction, lumbar), and M62.89 (other specified disorders of muscle). If any of those descriptors fit the clinical picture, use them instead.

In practice, M62.9 is appropriate when a provider documents a muscle disorder or myopathy by name but workup is incomplete or the etiology remains genuinely indeterminate at the time of the encounter. It is not appropriate as a proxy for symptoms like weakness or pain — those have their own codes. If the disorder is caused by an underlying disease classified elsewhere, look to M63.8x (disorders of muscle in diseases classified elsewhere), which requires a primary-condition code first.

M62.9 groups into MS-DRGs 557 (tendonitis, myositis and bursitis with MCC) and 558 (without MCC) under v43.0, so payers will scrutinize medical necessity. Documentation must affirmatively explain why a specific diagnosis could not be reached — not simply omit it.

Sibling codes

Other billable codes under M62 (laterality / anatomic variants).

M62.3

Immobility syndrome (paraplegic)

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01When is M62.9 appropriate versus M62.89?

Use M62.89 (other specified disorders of muscle) when the provider has identified a specific named condition that lacks its own dedicated ICD-10 code. Use M62.9 only when the disorder is confirmed but genuinely cannot be characterized further — no etiology, no specific type, no named syndrome.

02Can M62.9 be used for generalized muscle weakness?

No. Generalized muscle weakness has its own billable code: M62.81. M62.9 requires a documented muscle disorder, not a symptom. Assigning M62.9 for weakness alone is a specificity error.

03Should M62.9 be updated after diagnostic workup?

Yes. M62.9 is appropriate only when the diagnosis is genuinely indeterminate. Once EMG, muscle biopsy, or laboratory results establish a specific disorder, update the code to the most specific available option within M60-M63 or elsewhere in the tabular list.

04Does M62.9 require a secondary code for underlying disease?

Not inherently. If the muscle disorder is secondary to a disease classified elsewhere, the correct parent code is M63.8x (disorders of muscle in diseases classified elsewhere), which does require the underlying condition coded first. M62.9 is used when no underlying cause is established.

05What MS-DRGs does M62.9 map to?

M62.9 groups to MS-DRG 557 (tendonitis, myositis and bursitis with MCC) and 558 (without MCC) under v43.0. Payers reviewing these DRGs will expect documentation that supports medical necessity for the unspecified designation.

06Is M62.9 valid for orthopedic outpatient claims?

It is billable, but expect scrutiny. Orthopedic payers and RAC auditors look for specificity. Always document why a more specific code was not assignable. If the clinical picture fits M62.81, M62.82, M62.83x, M62.84, M62.85, or M62.89, use that code instead.

07Can M62.9 be used as a primary diagnosis with physical therapy CPT codes like 97110?

Technically M62.9 is a billable primary diagnosis, but many payers require more specific documentation of the condition being treated before approving 97110 or 97112 under a generic unspecified code. Document functional deficits and therapeutic goals explicitly to support medical necessity.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira Scribe

The Mira AI Scribe captures the provider's statement that a muscle disorder is present but cannot yet be further classified, along with the affected region(s), symptom duration, functional limitations, and a note that workup is pending or inconclusive. This prevents downcoding to a symptom-level code (e.g., M79.3x) and provides the audit trail needed to justify an unspecified designation under MS-DRG 557/558 review.

See how Mira captures M62.9 documentation